No-needle, single-visit adult male circumcision with Unicirc: a multi-centre field trial

Peter S Millard, Norman D Goldstuck, Peter S Millard, Norman D Goldstuck

Abstract

Background: Voluntary medical male circumcision (VMMC) is a priority HIV preventive intervention. Current adult circumcision methods need improvement.

Methods: Field trial in 3 primary care centres. Minimally invasive VMMC using the Unicirc instrument following topical lidocaine/prilocaine anesthetic. Men were followed up at 1 and 4 weeks.

Results: We circumcised 110 healthy volunteers. Two men complained of transient burning pain during circumcision, but none required injectable anaesthesia. Median blood loss was 1ml and median procedure time was 9.0 min. There were 7 (6.3%) moderate complications (5 (4.5%) post-operative bleeds requiring suture and 2 (1.8%) post-operative infections) affecting 7 men. No men experienced significant wound dehiscence. 90.4% of men were fully healed at 4 weeks of follow-up and all were highly satisfied.

Conclusions: Use of topical anaesthesia obviates the need for injectable anesthetic and makes the Unicirc procedure nearly painless. Unicirc is rapid, easy to learn, heals by primary intention with excellent cosmetic results, obviates the need for a return visit for device removal, and is potentially cheaper and safer than other methods. Use of this method will greatly facilitate scale-up of mass circumcision programs.

Trial registration: ClinicalTrials.gov NCT02091726.

Conflict of interest statement

Competing Interests: This study was supported by Simunye Primary Health Care. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.

Figures

Fig 1. Unicirc placement.
Fig 1. Unicirc placement.
Fig 2. Excising the foreskin.
Fig 2. Excising the foreskin.
Fig 3. Applying cyanoacrylate adhesive.
Fig 3. Applying cyanoacrylate adhesive.
Fig 4. Flow diagram.
Fig 4. Flow diagram.
Fig 5. Four-week follow-up.
Fig 5. Four-week follow-up.

References

    1. Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009:CD003362. Epub 2009 Apr 17. 10.1002/14651858.CD003362.pub2
    1. World Health Organization. WHO Progress Brief—Voluntary medical male circumcision for HIV prevention in priority countries of East and Southern Africa, July 2014. Available: . Accessed 2014 Aug 12.
    1. Njeuhmeli E, Forsythe S, Reed J, Opuni M, Bollinger L, Heard N, et al. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med. 2011;8: e1001132 10.1371/journal.pmed.1001132
    1. Millard PS, Wilson HR, Goldstuck ND, Anaso C. Rapid, minimally invasive adult voluntary male circumcision: A randomised trial of Unicirc, a novel disposable device. S Afr Med J. 2014;104: 52–7. 10.7196/samj.7357
    1. Millard PS. Randomized controlled trial of open surgical vs. rapid, minimally-invasive voluntary adult male circumcision (NCT01877408). Available: . Accessed 2014 August 12.
    1. Millard PS. Rapid, Minimally-invasive voluntary adult male circumcision: a quasi-experimental study (NCT01998360). Available: . Accessed 2014 December 12.
    1. World Health Organization. Framework for Clinical Evaluation of Devices for Adult Male Circumcision. 2011. Available: . Accessed 2014 August 12.
    1. Millard PS, Wilson HR, Veldkamp PJ, Sitoe N. Rapid, minimally invasive adult voluntary male circumcision: A randomised trial. S Afr Med J. 2013;103: 736–42. 10.7196/samj.6856
    1. World Health Organization. Considerations for implementing models for optimizing the volume and efficiency of male circumcision services. 2010. Available: . Accessed 2014 August 12.

Source: PubMed

3
Abonneren